REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 18th, 2011 • Rosetta Genomics Ltd. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 16, 2011, between Rosetta Genomics Ltd., a company organized under the laws of the State of Israel (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
ORDINARY SHARES PURCHASE WARRANT ROSETTA GENOMICS LTD.Security Agreement • February 18th, 2011 • Rosetta Genomics Ltd. • Pharmaceutical preparations
THIS ORDINARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on November 24, 2014 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rosetta Genomics Ltd., a company organized under the laws of the State of Israel (the “Company”), up to ______ (the “Warrant Shares”) of the Company’s Ordinary Shares, NIS 0.01 par value per share (the “Ordinary Shares”) at the Exercise Price per Ordinary Share as set forth in Section 2(b) below. This Warrant is issued by the Company as of the date hereof pursuant to (i) Section A of the Engagement Letter, dated February 8, 2011, as amended on February 14, 2011, between the Company and Rodman & Renshaw, LLC and (ii) Section 4(2) of the
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 18th, 2011 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 16, 2011, between Rosetta Genomics Ltd., a company organized under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
ORDINARY SHARES PURCHASE WARRANT ROSETTA GENOMICS LTD.Ordinary Shares Purchase Warrant • February 18th, 2011 • Rosetta Genomics Ltd. • Pharmaceutical preparations
THIS ORDINARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rosetta Genomics Ltd., a company organized under the laws of the State of Israel (the “Company”), up to ______ (the “Warrant Shares”) of the Company’s Ordinary Shares, NIS 0.01 par value per share (the “Ordinary Shares”) at the Exercise Price per Ordinary Share as set forth in Section 2(b) below.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 18th, 2011 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 16, 2011, between Rosetta Genomics Ltd., a company organized under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
